Global Cardiac Markers Rapid Tests and Point of Care (POC) Market, By Type (Troponin Rapid Tests and Point of Care Testing, Brain Natriuretic Peptide (BNP) Rapid Tests and Point of Care Testing, Other Cardiac Markers Rapid Tests and Point of Care Testing), Product (Reagents, Instruments), Testing (Lab, Point of Care), End-Users (Professional Diagnostic Centers, Hospitals/Critical Care Centers, Home Care Settings, Research Laboratories, Others) – Industry Trends and Forecast to 2030.
Cardiac Markers Rapid Tests and Point of Care (POC) Market Analysis and Size
The global cardiac markers rapid tests and point of care (POC) market is a vital segment within the healthcare industry, driven by the increasing prevalence of cardiovascular diseases (CVDs) worldwide. These tests are critical in diagnosing heart-related conditions swiftly, enabling immediate medical intervention and saving lives. As the global population ages and the incidence of heart diseases rises, the demand for rapid and accurate cardiac marker tests at the point of care has significantly escalated.
Data Bridge Market Research analyses that the global cardiac markers rapid tests and point of care (POC) market which was USD 137.46 million in 2022, is expected to reach USD 1303 million by 2030, and is expected to undergo a CAGR of 13.6% during the forecast period of 2023 to 2030. “Troponin Rapid Tests and Point of Care Testing dominates the type segment of the global cardiac markers rapid tests and point of care (POC) market owing to rising cardiovascular disease incidence. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cardiac Markers Rapid Tests and Point of Care (POC) Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (, Brain Natriuretic Peptide (BNP) Rapid Tests and Point of Care Testing, Other Cardiac Markers Rapid Tests and Point of Care Testing), Product (Reagents, Instruments), Testing (Lab, Point of Care), End-Users (Professional Diagnostic Centers, Hospitals/Critical Care Centers, Home Care Settings, Research Laboratories, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of the Middle East and Africa
|
|
Market Players Covered
|
Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthcare Private Limited (Germany), Beckman Coulter, Inc. (U.S.), BD (Becton, Dickinson and Company) (U.S.), Johnson & Johnson Services, Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), Abaxis (U.S.), Medtronic (Ireland), Opti Medical (U.S.), Sienco, Inc. (U.S.), Alpha Scientific Electronics (Taiwan), AccuBioTech Co., Ltd. (China), ACON Laboratories, Inc. (U.S.), bioMérieux, Inc. (France), Ortho Clinical Diagnostics (U.S.), Randox Laboratories Ltd. (U.K.)
|
|
Market Opportunities
|
|
Market Definition
Cardiac markers rapid tests and point of care (POC) diagnostics refer to medical tests conducted near the patient, usually at the bedside, doctor's office, clinic, or home, to swiftly detect specific biomarkers associated with cardiovascular diseases (CVDs). These biomarkers, also known as cardiac markers, include proteins, enzymes, and other molecules released into the bloodstream in response to heart-related conditions such as heart attacks, myocardial infarction, or other cardiac events.
Global Cardiac Markers Rapid Tests and Point of Care (POC) Market Dynamics
Drivers
- Increasing Cardiovascular Diseases (CVDs) Prevalence
The rising incidence of cardiovascular diseases globally, including heart attacks and strokes, drives the demand for rapid cardiac markers tests. Early diagnosis and monitoring are crucial, leading to increased market demand.
- Growing Aging Population and Rise in Diseases
The aging population, and the prevalence of cardiovascular diseases increases. The elderly are more prone to heart related issues, necessitating regular cardiac marker testing, thus driving the market growth.
- Advancements in Point of Care Technology
Continuous technological advancements, such as portable and user-friendly POC devices, enhance the accessibility and accuracy of cardiac marker tests. Improved technology encourages adoption, driving market expansion.
- Demand for Rapid Results and Immediate Treatment
Rapid cardiac marker tests provide quick results, allowing for immediate medical intervention if necessary. Hospitals and emergency settings increasingly rely on these rapid tests to make timely decisions, fueling market growth.
Opportunities
- Home Based Reliable Testing Kits
The development of reliable home based cardiac marker testing kits provides a significant market opportunity. With a shift toward self-monitoring, convenient and accurate home testing kits are in demand, especially among individuals with a history of heart diseases.
- Integration of Biomarkers and Advanced Technologies
Integrating multiple cardiac biomarkers and utilizing advanced technologies such as biosensors and wearable devices opens opportunities for more comprehensive and real-time cardiac health monitoring, expanding the market scope.
Restraints/Challenges
- Regulatory and Approval Challenges
Stringent regulatory approval processes for new cardiac marker tests pose a challenge. Meeting regulatory standards and obtaining approvals can be time-consuming and resource-intensive, hindering market entry.
- Limited Sensitivity and Specificity of Tests
Some rapid tests may have limitations in terms of sensitivity and specificity. False-positive or false-negative results can lead to misdiagnosis or delayed treatment, impacting the reliability of these tests.
- Competition from Established Diagnostic Methods
Traditional diagnostic methods such as laboratory-based tests and imaging techniques are well-established. Convincing healthcare providers and professionals to shift from proven methods to rapid tests presents a challenge.
- Cost Constraints and Reimbursement Issues
Cost constraints, both for healthcare providers and patients, impact the adoption of cardiac marker tests. In addition, reimbursement challenges in various healthcare systems can limit market growth.
This global cardiac markers rapid tests and point of care (POC) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cardiac markers rapid tests and point of care (POC) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Cardiac Markers Rapid Tests and Point of Care (POC) Market Scope
The global cardiac markers rapid tests and point of care (POC) market is segmented on the basis of products, surgery, end-user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Type
- Troponin Rapid Tests and Point Of Care Testing
- Brain Natriuretic Peptide (BNP) Rapid Tests and Point Of Care Testing
- Other Cardiac Markers Rapid Tests and Point Of Care Testing
Product
- Reagents
- Instruments
- Chemiluminescence
- Immunofluorescence
- Elisa
- Immunochromatography
Testing
- Lab
- Hospital Labs
- Reference Labs
- Contract Testing Labs
- Point of Care
End-Users
- Professional Diagnostic Centers
- Hospitals/Critical Care Centers
- Home Care Settings
- Research Laboratories
- Others
Global Cardiac Markers Rapid Tests and Point of Care (POC) Market Regional Analysis/Insights
The global cardiac markers rapid tests and point of care (POC) market is analysed and market size insights and trends are provided by country, products, surgery, end-users, and distribution channel as referenced above.
The countries covered in the global cardiac markers rapid tests and point of care (POC) market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global cardiac markers rapid tests and point of care (POC) market due to high adoption rate of advanced technology and the presence of skilled professionals within the region.
Asia-Pacific is expected to show a rapid and lucrative growth rate in the global cardiac markers rapid tests and point of care (POC) market during the forecast period of 2023 to 2030 owing to the growing foreign direct investments, increase in disposable incomes and rising awareness about advanced and minimally invasive surgical techniques in patients.
The country section of the market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. The market is analysed and market size insights and trends are provided by country, product, indication and end user as referenced above.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global cardiac markers rapid tests and point of care (POC) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global cardiac markers rapid tests and point of care (POC) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on global cardiac markers rapid tests and point of care (POC) market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Cardiac Markers Rapid Tests and Point of Care (POC) Market Share Analysis
The global cardiac markers rapid tests and point of care (POC) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global cardiac markers rapid tests and point of care (POC) market.
Some of the major players operating in the global cardiac markers rapid tests and point of care (POC) market are:
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Siemens Healthcare Private Limited (Germany)
- Beckman Coulter, Inc. (U.S.)
- BD (Becton, Dickinson and Company) (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- Instrumentation Laboratory (U.S.)
- PTS Diagnostics (U.S.)
- Abaxis (U.S.)
- Medtronic (Ireland)
- Opti Medical (U.S.)
- Sienco, Inc. (U.S.)
- Alpha Scientific Electronics (Taiwan)
- AccuBioTech Co., Ltd. (China)
- ACON Laboratories, Inc. (U.S.)
- bioMérieux, Inc. (France)
- Ortho Clinical Diagnostics (U.S.)
- Randox Laboratories Ltd. (U.K.)
SKU-